To confirm the effects of the αCD38‐tLNPs on the therapeutic outcome, αCD38‐ or iso‐tLNPs encapsulating siRNA‐CKAP5 composed of lipid 10 were used to transfect primary MM cells ex vivo. Here, CKAP5 is linked to Miyoshi myopathy.